Article metrics

Download PDFPDF

The MEK inhibitor selumetinib complements CTLA-4 blockade by reprogramming the tumor immune microenvironment

 

Online download statistics by month:

Online download statistics by month: December 2019 to May 2022

AbstractFullPdf
Dec 2019110
Jan 2020552
Feb 2020771
Mar 202030307
Apr 202025257
May 2020313114
Jun 202017174
Jul 202017173
Aug 2020885
Sep 202029296
Oct 202031319
Nov 202012124
Dec 202039394
Jan 202125255
Feb 202121217
Mar 202134349
Apr 2021303014
May 202121214
Jun 202129293
Jul 202130309
Aug 2021313112
Sep 2021323212
Oct 202137378
Nov 202132327
Dec 202143437
Jan 202244475
Feb 202245486
Mar 2022606114
Apr 2022697012
May 2022869116
Total921934216